...
首页> 外文期刊>British Journal of Pharmacology >Cardiac and gastric effects of histamine H_2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity
【24h】

Cardiac and gastric effects of histamine H_2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity

机译:组胺H_2受体拮抗剂的心脏和胃功能:亲脂性与受体亲和力之间没有相关性的证据

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

1 A series of histamine H_2 receptor antagonists with different lipophilicity were tested in cardiac and gastric assays in order to reveal possible differences in receptor affinity. Lipophilicity of the compounds was expressed as CLOG P (theoretically-determined logarithm of octanol:water partition coefficient) and log κ' (logarithm of capacity factor, experimentally-determined by reverse-phase high performance liquid chromatography). 2 Aminopotentidine (APT) and iodoaminopotentidine (I-APT), which are both lipophilic compounds, behaved as insurmountable antagonists of histamine responses in rat isolated gastric fundus (pK_B = 6.20 ± 0.16 and 6.89 ± 0.19, respectively) and guinea-pig isolated papillary muscle (pK_B = 6.34 ± 0.37 and 6.81 ±0.26, respectively). They were approximately as effective as ranitidine (RAN) in reducing histamine-induced acid secretion in the anaesthetized rat, ID_(50) values being 0.018 ± 0.02, 0.020 ± 0.03 and 0.036 ± 0.01 μmol kg~(-1) i.v. for APT, I-APT and RAN, respectively. Both APT and I-APT had a significantly longer duration of action than RAN. 3 The hydrophilic compound, SK&F 92857, was inactive up to 10 μM in modifying histamine-induced acid secretion in the isolated rat stomach. In the papillary muscle, low concentrations (0.1-1 μM) of this compound produced a competitive antagonism of the histamine responses (pA_2 value = 7.38± 0.11), while a higher concentration (10 μM) significantly reduced the maximal response to histamine. 4 RAN competitively antagonized histamine effects with a comparable affinity in cardiac and gastric preparations (pA_2 values were 6.42 ± 0.09 and 6.78±0.38 in heart and stomach, respectively). 5 Results obtained in this study clearly showed that the discrepancies between gastric and cardiac effects observed for some H_2 antagonists are not explained solely by differences in lipophilicity of compounds. Moreover, the significant correlation found between CLOG P and log κ' parameter, which takes into account, besides their lipophilicity, the ionization of the molecules, suggests that ionization has a similar influence for all the molecules on the partition between the lipophilic and aqueous phase.
机译:1在心脏和胃部试验中测试了一系列具有不同亲脂性的组胺H_2受体拮抗剂,以揭示受体亲和力的可能差异。化合物的亲脂性表示为CLOG P(理论上确定的辛醇:水分配系数的对数)和logκ'(容量因子的对数,通过反相高效液相色谱实验确定)。 2都是亲脂性化合物的氨基戊定(APT)和碘氨基戊定(I-APT)在大鼠离体胃底(分别为pK_B = 6.20±0.16和6.89±0.19)和豚鼠离体的乳头状组织中作为组胺反应的不可逾越的拮抗剂肌肉(pK_B分别为6.34±0.37和6.81±0.26)。它们在降低麻醉大鼠中组胺诱导的酸分泌方面与雷尼替丁(RAN)大致相同,ID_(50)值为i.v.0.018±0.02、0.020±0.03和0.036±0.01μmolkg〜(-1)。分别用于APT,I-APT和RAN。 APT和I-APT的作用持续时间均比RAN更长。 3高达10μM的亲水性化合物SK&F 92857在改变组胺诱导的大鼠胃酸分泌方面无活性。在乳头肌中,低浓度(0.1-1μM)的该化合物对组胺反应产生竞争性拮抗作用(pA_2值= 7.38±0.11),而较高的浓度(10μM)则明显降低了对组胺的最大反应。 4 RAN竞争性拮抗组胺作用,在心脏和胃部制剂中具有可比的亲和力(pA_2值在心脏和胃中分别为6.42±0.09和6.78±0.38)。 5从这项研究中获得的结果清楚地表明,对于某些H_2拮抗剂观察到的胃和心脏效应之间的差异并不能仅通过化合物的亲脂性差异来解释。此外,CLOG P和logκ'参数之间存在显着相关性,除了亲脂性外,还考虑了分子的电离,这表明电离对所有分子对亲脂相和水相之间的分配具有相似的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号